Alterity Therapeutics (ATHE) vs Xilio Therapeutics (XLO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Xilio Therapeutics (XLO) has outperformed Alterity Therapeutics (ATHE) over the past year, losing 21.7% versus a loss of 22.4%. Alterity Therapeutics is the larger company by market cap ($60.5 million vs $59.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ATHE | XLO |
|---|---|---|
| Share price | $3.32 | $9.01 |
| Market cap | $60.45M | $59.29M |
| 1-day change | -1.48% | +0.11% |
| YTD return | +7.79% | +0.56% |
| 1-year return | -22.43% | -21.71% |
| 5-year return | -74.66% | — |
| EPS (TTM) | $-0.89 | $-0.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.89 | $12.59 |
| 52-week low | $2.66 | $6.47 |
| Distance from 52-week high | -43.63% | -28.41% |
| Average volume | 16.28K | 20.06K |
| Shares outstanding | 18.21M | 6.58M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ATHE vs XLO FAQ
Which is bigger, Alterity Therapeutics or Xilio Therapeutics?
Alterity Therapeutics (ATHE) is larger, with a market capitalization of $60.45M compared with $59.29M for Xilio Therapeutics (XLO).
Which stock has performed better over the past year, ATHE or XLO?
XLO returned -21.71% over the past 12 months, compared with -22.43% for ATHE (price return, excluding dividends). Past performance does not predict future results.
Are Alterity Therapeutics and Xilio Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.